Graham J. Durant - Concepedia

Author

Graham J. Durant

Cambridge Scientific (United States)

Also Known As

GRAHAM J. DURANT, Graham Durant, Graham J Durant, Graham J. Durant

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Cambridge Scientific (United States)University of Toledo

About

Graham J. Durant is an author at Cambridge Scientific (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	718
2	Engineering	8	8	241
3	Natural Sciences	6	6	406
4	Social Sciences	1	1	72
5	Allergy	1	1	260

Graham J. Durant

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Chemical differentiation of histamine H1- and H2-receptor agonists Graham J. Durant, C. Robin Ganellin, Michael E. Parsons Journal of Medicinal Chemistry Medicinal ChemistryAllergyBiochemistryFunctional SelectivityMedicine	1975	260
Synthesis and Pharmacological Evaluation of <i>N</i>-(2,5-Disubstituted phenyl)-<i>N</i>‘-(3-substituted phenyl)-<i>N</i>‘-methylguanidines As <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor Ion-Channel Blockers Lain‐Yen Hu, Junqing Guo, Sharad S. Magar, Journal of Medicinal Chemistry Synaptic TransmissionNeurotransmitterPharmacotherapyExperimental PharmacologyGlutamate Receptors	1997	82
Asymmetric synthesis of a neuroprotective and orally active N-methyl-d-aspartate receptor ion-channel blocker, CNS 5788 Seetharamaiyer Padmanabhan, Ruth C. Lavin, Graham J. Durant Tetrahedron Asymmetry Molecular NeuroscienceMedicineNeurotransmitterAsymmetric SynthesisNeuropharmacology	2000	72
Potential histamine H2-receptor antagonists. 3. Methylhistamines Graham J. Durant, J. C. EMMETT, C. Robin Ganellin, Journal of Medicinal Chemistry	1976	70
Theoretical studies on hydration of pyrrole, imidazole, and protonated imidazole in the gas phase and aqueous solution Péter Nagy, Graham J. Durant, Douglas A. Smith Journal of the American Chemical Society Chemical EngineeringMolecular SciencesEngineeringChemical MeasurementChemical Analysis	1993	58
Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[125I]-iodophenyl)-N′-methylguanidine ([125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation Jonathan Owens, Andrew A Tebbutt, Ailsa L. McGregor, Nuclear Medicine and Biology EngineeringBiochemistryFunctional SelectivityMedicineMechanism Of Action	2000	53
Theoretical Analyses of the Tautomeric and Conformational Equilibria of Histamine and (.alpha.R,.beta.S)-.alpha.,.beta.-Dimethylhistamine in the Gas Phase and Aqueous Solution Peter I. Nagy, Graham J. Durant, Wayne Hoss, Journal of the American Chemical Society Chemical KineticsEngineeringChemical AnalysisAltmetric Attention ScoreOrganic Chemistry	1994	49
Dipole moment in relation to hydrogen receptor histamine antagonist activity for cimetidine analogs Rodney C. Young, Graham J. Durant, John C. Emmett, Journal of Medicinal Chemistry	1986	45
Design, Synthesis, and Pharmacological Evaluation of Conformationally Constrained Analogues of <i>N</i>,<i>N</i>‘-Diaryl- and <i>N</i>-Aryl-<i>N</i>-aralkylguanidines as Potent Inhibitors of Neuronal Na<sup>+</sup> Channels Michel Maillard, Michael E. Perlman, Oved Amitay, Journal of Medicinal Chemistry	1998	44
Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists Philip G. Dunbar, Graham J. Durant, Zheng Fang, Journal of Medicinal Chemistry	1993	43

Page 1